Controversial Alzheimer’s drug approval sparks surprising impact
When the U.S. Food and Drug Administration gave controversial accelerated approval to the first Alzheimer’s drug in nearly 20 years,…
When the U.S. Food and Drug Administration gave controversial accelerated approval to the first Alzheimer’s drug in nearly 20 years,…
A Cornell-led collaboration used machine learning to pinpoint the most accurate means, and timelines, for anticipating the advancement of Alzheimer’s…
The brains of people with Down syndrome develop the same neurodegenerative tangles and plaques associated with Alzheimer’s disease and frequently…
The Alzheimer’s Association is disappointed by the topline Phase 3 data reported today by Genentech and Roche from the GRADUATE…
A large study led by Lund University in Sweden has shown that people with Alzheimer’s disease can now be identified…
Considering how patients from different ethnic groups respond to the same drug could be crucial to finding new Alzheimer’s disease…
Researchers from Hokkaido University and Toppan have developed a method to detect build-up of amyloid β in the brain, a…
Case Western Reserve University researchers have identified a mechanism in brain tissue that may explain why women are more vulnerable…
Older people who were infected with COVID-19 show a substantially higher risk—as much as 50% to 80% higher than a…
A newly developed agonistic antibody reduced the amyloid pathology in mice with Alzheimer’s disease, signaling its promise as a potential…
Researchers have developed a new method to identify people who are at greater genetic risk of developing Alzheimer’s disease before…
A new MIT study finds that Alzheimer’s disease disrupts at least one form of visual memory by degrading a newly…
Neurophysiological techniques (e.g., electroencephalography, EEG, transcranial magnetic stimulation, TMS) allow an informed investigation of the brain overexcitability underpinning the typical…
The discovery of how to shift damaged brain cells from a diseased state into a healthy one presents a potential new…
Mount Sinai researchers have achieved an unprecedented understanding of the genetic and molecular machinery in human microglia—immune cells that reside…
One of the hallmarks of Alzheimer’s disease is a reduction in the firing of some neurons in the brain, which…
An estimated 50 million people around the world have Alzheimer’s disease (AD), and perhaps twice that number are unknowingly “incubating”…
People with gut disorders may be at greater risk of developing Alzheimer’s Disease (AD). A world-first Edith Cowan University (ECU)…
COVID-19 positive outpatients are at an increased risk of neurodegenerative disorders compared with individuals who tested negative for the virus,…
A new study has revealed how tau – a microtubule-binding protein that is implicated in Alzheimer’s disease – weakens transmission…
The number of elderly suffering from Alzheimer’s Disease has been rapidly rising over the past decades. For a long time,…
The research uses machine learning technology to look at structural features within the brain, including in regions not previously associated…
Dementia is one of the major causes of disability and dependency among older people worldwide, affecting thinking and behaviours as…
As rates of Alzheimer’s disease and other forms of dementia continue to rise in the U.S., new evidence suggests that…
Researchers from The University of Texas Health Science Center at San Antonio (UT Health San Antonio) have found that oral…
In work presented at the 2022 EULAR Congress, Dr Jens Kristian Pedersen and colleagues used data from the DANBIO registry…
In a new study of Alzheimer’s disease, researchers at UC San Francisco have discovered that a relatively unstudied form of…
For more than 20 years, scientists have known that people with hypertension, diabetes, high cholesterol, or obesity have a higher…
Breakthrough COVID-19 cases resulting in infections, hospitalizations and deaths are significantly more likely in cancer and Alzheimer’s patients, according to…
As explained by Francisco Camarena, researcher at the Institute of Instrumentation for Molecular Imaging, a joint center between the UPV…